Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies

Rheumatology (United Kingdom)

Volumn 55, Issue 3, 2016, Pages 441-449

  Yao, Lawrence ^a   Yip, Adrienne L ^b   Shrader, Joseph A ^c   Mesdaghinia, Sepehr ^b   Volochayev, Rita ^b   Jansen, Anna V ^b   Miller, Frederick W ^b   Rider, Lisa G ^b  

^a CLINICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Dermatomyositis; Fat fraction; Idiopathic inflammatory myopathies; Juvenile dermatomyositis; MRI; Muscle; Myositis; Polymyositis; T2

Indexed keywords

PREDNISONE; RITUXIMAB;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; CHILDHOOD MYOSITIS ASSESSMENT SCALE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONSTRUCT VALIDITY; CONTENT VALIDITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DERMATOMYOSITIS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY SCORE; FAT CONTENT; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; IMAGING SOFTWARE; JUVENILE DERMATOMYOSITIS; MALE; MIDDLE AGED; MUSCLE; MUSCLE INJURY; MYOSITIS; MYOSITIS DISEASE ACTIVITY ASSESSMENT TOOL MUSCLE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PHYSICIAN GLOBAL ACTIVITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; RATING SCALE; SHORT TAU INVERSION RECOVERY; STANDARDIZATION;

EID: 84965044071     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kev344     Document Type: Article

References (33)

1. Rider LG, Miller FW. Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. JAMA 2011;305:183-90.
2. Fraser DD, Frank JA, Dalakas M et al. Magnetic resonance imaging in the idiopathic inflammatory myopathies. J Rheumatol 1991;18:1693-700.
3. Maillard SM, Jones R, Owens C et al. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology 2004;43:603-8.
4. Gold GE, Han E, Stainsby J et al. Musculoskeletal MRI at 3.0 T: relaxation times and image contrast. AJR Am J Roentgenol 2004;183:343-51.
5. Poon CS, Szumowski J, Plewes DB, Ashby P, Henkelman RM. Fat/water quantitation and differential relaxation time measurement using chemical shift imaging technique. Magn Reson Imaging 1989;7:369-82.
6. de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 2004;230:652-9.
7. Yao L, Gai N. Fat-corrected T2 measurement as a marker of active muscle disease in inflammatory myopathy. AJR Am J Roentgenol 2012;198:W475-81.
8. Janiczek RL, Gambarota G, Sinclair CD et al. Simultaneous T2 and lipid quantitation using IDEALCPMG. Magn Reson Med 2011;66:1293-302.
9. Rider LG, Werth VP, Huber AM et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis. Arthritis Care Res 2011;63:S118-57.
10. Bohan A, Peter JB. Polymyositis and dermatomyositi. Parts 1 and 2. N Engl J Med 1975;292:344-7, 403-407.
11. Oddis CV, Reed AM, Aggarwal R et al. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum 2013;65:314-24.
12. Rider LG, Koziol D, Giannini EH et al. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res 2010;62:465-72.
13. Isenberg DA, Allen E, Farewell V et al. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology 2004;43:49-54.
14. Varni JW, Seid M, Knight TS et al. The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module. Arthritis Rheum 2002;46:714-25.
15. Varni JW, Burwinkle TM, Szer IS. The PedsQL Multidimensional Fatigue Scale in pediatric rheumatology:reliability and validity. J Rheumatol 2004;31:2494-500.
16. Miller FW, Rider LG, Chung YL et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology 2001;40:1262-73.
17. Rider LG, Giannini EH, Brunner HI et al. International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 2004;50:2281-90.
18. Wilkinson MHF. Gaussian-weighted moving-window robust automatic threshold selection. In: Petkov N, Westenberg MA, eds. Computer analysis of images and patterns. Proceedings of the 10th International Conference, CAIP, 2003, Groningen, The Netherlands, 25-27 August, 2003: 369-376.
19. Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 2000;53:459-68.
20. Bessette L, Sangha O, Kuntz KM et al. Comparative responsiveness of generic versus disease-specific and weighted versus unweighted health status measures in carpal tunnel syndrome. Med Care 1998;36:491-502.
21. McHugh ML. Interrater reliability: the kappa statistic. Biochem Med 2012;22:276-82.
22. Shuman WP, Lambert DT, Patten RM, Baron RL, Tazioli PK. Improved fat suppression in STIR MR imaging: selecting inversion time through spectral display. Radiology 1991;178:885-7.
23. Kimball AB, Summers RM, Turner M et al. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy. Arthritis Rheum 2000;43:1866-73.
24. Kim HK, Laor T, Horn PS et al. T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology 2010;255:899-908.
25. Hu HH, Kan HE. Quantitative proton MR techniques for measuring fat. NMR Biomed 2013;26:1609-29.
26. Gaeta M, Messina S, Mileto A et al. Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience. Skeletal Radiol 2012;41:955-61.
27. Triplett WT, Baligand C, Forbes SC et al. Chemical shiftbased MRI to measure fat fractions in dystrophic skeletal muscle. Magn Reson Med 2014;72:8-19.
28. Malattia C, Damasio MB, Madeo A et al. Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis. Ann Rheum Dis 2014;73:1083-90.
29. Dorph C, Englund P, Nennesmo I, Lundberg IE. Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis. Ann Rheum Dis 2006;65:1565-71.
30. Rayavarapu S, Coley W, Kinder TB, Nagaraju K. Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness. Skelet Muscle 2013;3:13.
31. Foltz WD, Stainsby JA, Wright GA. T2 accuracy on a whole-body imager. Magn Reson Med 1997;38:759-68.
32. Maier CF, Tan SG, Hariharan H, Potter HG. T2 quantitation of articular cartilage at 1.5 T. J Magn Reson Imaging 2003;17:358-64.
33. Azzabou N, Loureiro de Sousa P, Caldas E, Carlier PG. Validation of a generic approach to muscle water T2 determination at 3T in fat-infiltrated skeletal muscle. J Magn Reson Imaging 2015;41:645-53.